Company Profile

AndCare Inc (AKA: Enzyme Technology Research Group Inc~Alderon Biosciences Inc)
Profile last edited on: 1/22/2019      CAGE: 0K7W0      UEI:

Business Identifier: Electrochemical sensing technologies
Year Founded
1985
First Award
1986
Latest Award
2003
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2810 Meridian Parkway Suite 152
Durham, NC 27713
   (919) 544-8220
   info@alderonbiosciences.com
   www.alderonbiosciences.com
Location: Single
Congr. District: 01
County: Durham

Public Profile

Previously called Enzyme Technology Research Group Inc, Ancare is now part of the entity Alderon Biosciences Inc. Andcare is organized around providing simpler, faster, and more economical diagnostic systems for medical, environmental, and laboratory research and testing needs. The company's novel electrochemical assay products are designed for the detection of metals (lead), peroxide, nucleic acids, proteins, and antigens. These provide alternative, low-cost, simple to use diagnostic systems for medical, environmental, and laboratory research and testing needs. The firm's Core Technology are Unique electrode surfaces modified with colloidal gold or biomaterials including enzymes, antibodies, other proteins, and gene probes Disposable Electrochemical Sensors Portable Electrochemical Instruments. One project of note was the first FDA approved hand-held blood lead detection device. Collaborative efforts with the CDC and USAID by AndCare personnel took this device to several third world countries where it found extensive use.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2003 2 NIH $359,546
Project Title: Innovative Technology for Gene Expression Studies
2003 2 NIH $1,899,438
Project Title: New Single Nucleotide Polymorphism (SNP) Scoring System
2002 2 NIH $811,423
Project Title: Electrochemical Enzyme Immunoassay To Test Blood HBV
2001 1 NIH $300,000
Project Title: Tools For Gene-Expression Studies Of Malaria
2001 1 NIH $99,277
Project Title: Electrochemical Molecular Arrays for Drug Development

Key People / Management

  Robert W Henkens -- President

  Steven E Wegner -- President and CEO

  Philip A Brown

  Carolyn Henkens

  Barbara S Kitchell

  John P O'Daly

  Marek Wojciechowski -- Director of Research & Developmen

  Junguo Zhao

Company News

There are no news available.